Journal profile · MEDICINE, GENERAL & INTERNAL
Acta Medica Indonesiana
ISSN 0125-9326 · eISSN 2338-2732 · Interna Publishing · Indonesia
Acta Medica Indonesiana: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 500; review about 12 weeks (community reports); 69 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Acta Medica Indonesiana is published by Interna Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, Liver Disease Diagnosis and Treatment and Long-Term Effects of COVID-19, together about 21.1% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Acta Medica Indonesiana – The Indonesian Journal of Internal Medicine is a comprehensive peer-reviewed medical journal owned and published by The Indonesian Society of Internal Medicine. Our main mission is to encourage novel and important science in the clinical area of internal medicine. Acta Medica Indonesiana is an open-access online journal. We welcome authors for research articles, review articles, case reports, special articles, clinical practices, and medical illustrations in the clinical area of internal medicine. Authors are invited to submit articles that have not been published previously and are not under consideration elsewhere. Preparations of the manuscript should follow the “Author Guidelines” in the submission section. Our journal has been accredited by SINTA 1 (DIKTI) and indexed by PubMed/MEDLINE, SCOPUS, EBSCO, DOAJ, Emerging Science Citation Index (ESCI by Web of Science/ Clarivate), Asean Citation Index, WorldCat, and Google Scholar. Acta Medica Indonesiana also participates in the CLOCKSS (Controlled Lots of Copies Keep Stuff Safe) archival system to ensure permanent access for the journal's publishing.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editorial board by country: none in mainland China; most named Indonesia 27, Japan 2, Australia 1, Netherlands 1, Thailand 1 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine9.1%
- Liver Disease Diagnosis and TreatmentMedicine6.4%
- Long-Term Effects of COVID-19Medicine5.5%
- Nutrition and Health in AgingMedicine5.3%
- Tuberculosis Research and EpidemiologyMedicine5.1%
- Dialysis and Renal Disease ManagementMedicine5.1%
- Frailty in Older AdultsMedicine5.1%
- Sepsis Diagnosis and TreatmentMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEWeb of ScienceMEDLINEPubMedPublisher website
Other: Google Scholar, EBSCO, Asean Citation Index, WorldCat
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.25LetPub ·
- h-index
- 32OpenAlex ·
- i10-index
- 130OpenAlex ·
- 2-year mean citedness
- 0.18OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 61LetPub ·
Articles by year OpenAlex count · 799 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 36 | 0 |
| 2025 | 69 | 69 | 7 |
| 2024 | 73 | 73 | 25 |
| 2023 | 71 | 71 | 91 |
| 2022 | 80 | 80 | 180 |
| 2021 | 69 | 69 | 311 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | IDR 7,500,000 / USD 500 | No | CC BY | |
| OpenAlex | IDR 7,500,000 / USD 500 | — | — | |
| LetPub | IDR 7,500,000 / USD 500 | No | — | |
| Publisher website | USD 725 / USD 450 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Reference style
- Vancouver
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright
- Authorship Authorship – The ICMJE Recommendation
This journal uses the guidelines for authorship and manuscript submission policies of ICMJE (https://www.icmje.org/).
Source ↗Publisher website ·- Conflicts of interest CONFLICT OF INTEREST (COI)
All authors must disclose any financial or non-financial conflicts of interest that could influence the content or interpretation of the manuscript. This includes, but is not limited to:
Source ↗Publisher website ·- Publication ethics PUBLICATION ETHICS AND MALPRACTICE STATEMENT
Publication ethics based on COPE and ICMJE guidelines Model summary
Acta Medica Indonesiana is committed to upholding the highest standards of publication ethics and taking all possible measures against publication malpractice. This statement is based on the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) guidelines. Studies on human subjects should have ethical clearance from the Institutional Review Board…
Source ↗Publisher website ·- License & copyright Copyright Notice
Copyright retained by authors, CC BY 4.0 license Model summary
COPYRIGHT The authors who publish in this journal agree to the following requirements: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journa…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Interna Publishing
- Country or region
- Indonesia
- Language
- English
- ISSN
- 0125-9326
- Electronic ISSN
- 2338-2732
- Latest issue on the website
- Volume 58, Issue 2 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Acta Medica Indonesiana
What CAS zone is Acta Medica Indonesiana in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Medica Indonesiana is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Acta Medica Indonesiana?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Acta Medica Indonesiana based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Indonesia (27), Japan (2) and Australia (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Medica Indonesiana?
According to LetPub and DOAJ records, Acta Medica Indonesiana is indexed in ESCI, Scopus and DOAJ. The journal's website also lists SCIE, Web of Science, MEDLINE and PubMed; that list has not been checked against each database.
Is Acta Medica Indonesiana open access, and what is the APC?
Acta Medica Indonesiana is a fully open-access journal. APC about USD 500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .